3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interaction gene set between osteoclasts and regulatory CD4 + T cells can accurately predict the prognosis of patients with osteosarcoma

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Osteoclasts (OCs) and regulatory CD4 + T cells (CD4 +Tregs) are important components in the tumor microenvironment (TME) of osteosarcoma. In this study, we collected six osteosarcoma samples from our previous study (GSE162454). We also integrated a public database (GSE152048), which included single cell sequencing data of 11 osteosarcoma patients. We obtained 138,192 cells and then successfully identified OCs and CD4 +Tregs. Based on the interaction gene set between OCs and CD4 +Tregs, patients from GSE21257 were distinguished into two clusters by consensus clustering analysis. Both the tumor immune microenvironment and survival prognosis between the two clusters were significantly different. Subsequently, five model genes were identified by protein–protein interaction network based on differentially upregulated genes of cluster 2. Quantitative RT‐PCR was used to detect their expression in human osteoblast and osteosarcoma cells. A prognostic model was successfully established using these five genes. Kaplan–Meier survival analysis found that patients in the high‐risk group had worse survival ( p = 0.029). Therefore, our study first found that cell–cell communication between OCs and CD4 +Tregs significantly alters TME and is connected to poor prognosis of OS. The model we constructed can accurately predict prognosis for osteosarcoma patients.

          Abstract

          This research found that cell–cell communication between osteoclasts and regulatory CD4 + T cells significantly alter the tumor microenvironment and is connected to poor prognosis of osteosarcoma. The model can accurately predict patient prognosis.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          limma powers differential expression analyses for RNA-sequencing and microarray studies

          limma is an R/Bioconductor software package that provides an integrated solution for analysing data from gene expression experiments. It contains rich features for handling complex experimental designs and for information borrowing to overcome the problem of small sample sizes. Over the past decade, limma has been a popular choice for gene discovery through differential expression analyses of microarray and high-throughput PCR data. The package contains particularly strong facilities for reading, normalizing and exploring such data. Recently, the capabilities of limma have been significantly expanded in two important directions. First, the package can now perform both differential expression and differential splicing analyses of RNA sequencing (RNA-seq) data. All the downstream analysis tools previously restricted to microarray data are now available for RNA-seq as well. These capabilities allow users to analyse both RNA-seq and microarray data with very similar pipelines. Second, the package is now able to go past the traditional gene-wise expression analyses in a variety of ways, analysing expression profiles in terms of co-regulated sets of genes or in terms of higher-order expression signatures. This provides enhanced possibilities for biological interpretation of gene expression differences. This article reviews the philosophy and design of the limma package, summarizing both new and historical features, with an emphasis on recent enhancements and features that have not been previously described.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cytoscape: a software environment for integrated models of biomolecular interaction networks.

            Cytoscape is an open source software project for integrating biomolecular interaction networks with high-throughput expression data and other molecular states into a unified conceptual framework. Although applicable to any system of molecular components and interactions, Cytoscape is most powerful when used in conjunction with large databases of protein-protein, protein-DNA, and genetic interactions that are increasingly available for humans and model organisms. Cytoscape's software Core provides basic functionality to layout and query the network; to visually integrate the network with expression profiles, phenotypes, and other molecular states; and to link the network to databases of functional annotations. The Core is extensible through a straightforward plug-in architecture, allowing rapid development of additional computational analyses and features. Several case studies of Cytoscape plug-ins are surveyed, including a search for interaction pathways correlating with changes in gene expression, a study of protein complexes involved in cellular recovery to DNA damage, inference of a combined physical/functional interaction network for Halobacterium, and an interface to detailed stochastic/kinetic gene regulatory models.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              GSVA: gene set variation analysis for microarray and RNA-Seq data

              Background Gene set enrichment (GSE) analysis is a popular framework for condensing information from gene expression profiles into a pathway or signature summary. The strengths of this approach over single gene analysis include noise and dimension reduction, as well as greater biological interpretability. As molecular profiling experiments move beyond simple case-control studies, robust and flexible GSE methodologies are needed that can model pathway activity within highly heterogeneous data sets. Results To address this challenge, we introduce Gene Set Variation Analysis (GSVA), a GSE method that estimates variation of pathway activity over a sample population in an unsupervised manner. We demonstrate the robustness of GSVA in a comparison with current state of the art sample-wise enrichment methods. Further, we provide examples of its utility in differential pathway activity and survival analysis. Lastly, we show how GSVA works analogously with data from both microarray and RNA-seq experiments. Conclusions GSVA provides increased power to detect subtle pathway activity changes over a sample population in comparison to corresponding methods. While GSE methods are generally regarded as end points of a bioinformatic analysis, GSVA constitutes a starting point to build pathway-centric models of biology. Moreover, GSVA contributes to the current need of GSE methods for RNA-seq data. GSVA is an open source software package for R which forms part of the Bioconductor project and can be downloaded at http://www.bioconductor.org.
                Bookmark

                Author and article information

                Contributors
                fengwenyu7381@126.com
                liuyun200450250@sina.com
                Journal
                Cancer Sci
                Cancer Sci
                10.1111/(ISSN)1349-7006
                CAS
                Cancer Science
                John Wiley and Sons Inc. (Hoboken )
                1347-9032
                1349-7006
                07 May 2023
                July 2023
                : 114
                : 7 ( doiID: 10.1111/cas.v114.7 )
                : 3014-3026
                Affiliations
                [ 1 ] Department of Spine and Osteopathic Surgery First Affiliated Hospital of Guangxi Medical University Nanning China
                [ 2 ] Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co‐constructed by the Province and Ministry Guangxi Medical University Nanning China
                [ 3 ] Department of Pharmacy First Affiliated Hospital of Guangxi Medical University Nanning China
                [ 4 ] Department of Radiotherapy Second Affiliated Hospital of Guangxi Medical University Nanning China
                [ 5 ] Department of Orthopedic and Hand Surgery First Affiliated Hospital of Guangxi Medical University Nanning China
                [ 6 ] Department of Burn and Plastic Surgery First Affiliated Hospital of Guangxi Medical University Nanning China
                [ 7 ] Department of Bone and Joint Surgery and Sports medicine Second Affiliated Hospital of Guangxi Medical University Nanning China
                Author notes
                [*] [* ] Correspondence

                Yun Liu, Department of Spine and Osteopathic Surgery, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Qingxiu District, Nanning 530021, Guangxi, China.

                Email: liuyun200450250@ 123456sina.com

                Wenyu Feng, Department of Bone and Joint Surgery and Sports medicine, Second Affiliated Hospital of Guangxi Medical University, 166 University East Road, Xixiang Tang District, Nanning 530007, Guangxi, China.

                Email: fengwenyu7381@ 123456126.com

                Author information
                https://orcid.org/0000-0002-3325-6761
                https://orcid.org/0000-0002-7745-1083
                Article
                CAS15821 CAS-OA-0205-2023.R1
                10.1111/cas.15821
                10323104
                37150900
                34005427-9e45-41e5-93d1-91dd9f580012
                © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 30 March 2023
                : 02 February 2023
                : 04 April 2023
                Page count
                Figures: 7, Tables: 0, Pages: 13, Words: 6467
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 81960768
                Award ID: 82260814
                Funded by: Natural Science Foundation of Guangxi Province , doi 10.13039/501100004607;
                Award ID: 2020GXNSFAA259088
                Funded by: Self‐raised project of Guangxi Zhuang Autonomous Region Health Committee
                Award ID: Z20200737
                Funded by: Youth Science and Technology Project of the First Affiliated Hospital of Guangxi Medical University
                Award ID: 201903038
                Funded by: Youth Science Foundation of Guangxi Medical University , doi 10.13039/501100012543;
                Award ID: GXMUYSF202129
                Award ID: GXMUYSF202313
                Categories
                Original Article
                ORIGINAL ARTICLES
                Genetics, Genomics and Proteomics
                Custom metadata
                2.0
                July 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.0 mode:remove_FC converted:06.07.2023

                Oncology & Radiotherapy
                cd4+treg,interaction gene set,osteoclast,osteosarcoma,single‐cell rna‐seq

                Comments

                Comment on this article